Company profile: BCI Pharma
1.1 - Company Overview
Company description
- Provider of kinase inhibitor discovery and development solutions, including a proprietary platform to identify novel, potent and selective kinase inhibitors for various diseases; medicinal chemistry and biology laboratories for design, synthesis and cell-based assay development; a preclinical candidate for peripheral neuropathic pain and psoriasis; and risk-sharing collaborations on kinase research projects.
Products and services
- Medicinal Chemistry Laboratory: Engineers and synthesizes innovative chemical entities to build kinase inhibitor libraries, enabling compound creation and optimization supporting treatments for inflammatory diseases, CNS disorders, and cancer
- Kinase Inhibitor Platform: Architects a proprietary discovery platform that identifies novel, potent, and selective kinase inhibitor hits for various diseases, supporting programs targeting inflammatory diseases, CNS disorders, and cancer
- Preclinical Candidate for Peripheral Neuropathic Pain and Psoriasis: Identified a preclinical therapeutic candidate aimed at treating peripheral neuropathic pain and psoriasis, aligning pipeline toward medications for these indications
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BCI Pharma
Batavia Biosciences
HQ: The Netherlands
Website
- Description: Provider of services accelerating the transition of biopharmaceutical product candidates from discovery to the clinic with improved success and lower cost, including candidate selection, production of research materials, upstream and downstream process development, assay development, and product characterization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Batavia Biosciences company profile →
Carbogen Amcis
HQ: Switzerland
Website
- Description: Provider of drug development and commercialization services to the pharmaceutical and biopharmaceutical industries, including CDMO support for drug substances and drug products, high potency API development and manufacturing, production of cholesterol, lanolin derivatives and vitamin D/D2 analogs, integrated analytical services, and non-GMP manufacturing of starting materials, intermediates, fine and specialty chemicals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Carbogen Amcis company profile →
Birgi Mefar
HQ: Turkey
Website
- Description: Provider of contract manufacturing of sterile parenteral solutions and suspensions, filling into ampoules, vials, lyo vials, pre-filled syringes and blow-fill-seal containers; manufacturer of primary packaging producing empty ampoules and vials from clear and amber glass tubing; lab services for stability studies, analytical method and process validation with scale-up; cGMP blistering, labeling, track and trace; GMP cold chain storage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Birgi Mefar company profile →
Prince Sterilization
HQ: United States
Website
- Description: Provider of medical device sterilization services, offering steam sterilization to eliminate all forms of microbial life, low-temp vaporized hydrogen peroxide sterilization for heat-sensitive equipment, and dry heat sterilization for materials that withstand high temperatures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prince Sterilization company profile →
Equalis
HQ: Sweden
Website
- Description: Provider of external quality assessment services for medical and diagnostic laboratories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Equalis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BCI Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BCI Pharma
2.2 - Growth funds investing in similar companies to BCI Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BCI Pharma
4.2 - Public trading comparable groups for BCI Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →